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A b s t r a c t  
A new 4Ê,6-dihydroxy,4-methoxybenzophenone-2-O--D-gentiobioside(1) was obtained from the 
leaves of Phaleriamacrocarpa (Scheff.) Boerl along with known 4Ê,6-dihydroxy,4-
methoxybenzophenone-2-O--D-glucoside (2). Bioactivity assays indicated that compound (1) and 
(2) have antioxidant activity and enhancement on SR-B1 genes expressionin vitro. Their structures 
compounds were established by the interpretation of their spectroscopic data and comparisonwith 
known compounds. 
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Introduction 
Plants are still the main source in search for the new medicine 
resources due to their advantages such as cheap, abundance, 
low toxicity, and low side effect if used with the right dosage. One 
of this example is MahkotaDewa(Phaleriamacrocarpa  (Scheff.) 
Boerl). The fruits of P. macrocarpa have been used as a 
traditional medicinein two forms. In freshly prepared or it consume 
as it is, like guava or as a mixture together with chili in fruit salad. 
Consumption of fresh fruit is very dangerous as it is toxic, causing 
serious effect such as mouth ulcer, numbness of the tongue, and 
drunk. Secondly, it has already processed into dried powder. It 
also can be combined with dried powder from other medicine 
plants to use as a traditional medicine (itÊs called ‰ jamu‰).  P. 
macrocarpa traditionally can be used to cure many diseases like 
cancer, hepatitis, heart, diabetes, skin diseases, rheumatism, 
bacterial and viral infection, hypercholesterolemia, and 
hypertension [1]. Some medicine products of P. macrocarpa fruits 
have already been marketed, i.e. for cancer or tumor treatment, 
stroke, hypertention, diabetes, uric acid, allergy, influenza, and 
brain supplement. Recently, P. macrocarpa fruit has been used in 
cosmetic products, such as shampoo, beauty powder, beauty 
soap, scrubs, hair spa, message oil, and balsam. While, leaves 
from P. macrocarpahas been used as tea for leaves tumor or 
cancer treatment. 
 
The therapeutic effect of natural material is related to the bioactive 
compounds. For instant, in P. macrocarpa  fruit mesocarp, there 
are many alkaloid, saponin, flavonoid and tannin compounds. 
While it leaves contains alkaloid, flavonoid, saponindanpolifenol 
[2]. Subsequently, P. macrocarpa seed contains some 
compounds such as alkaloid, flavonoid, polifenol, and tannin 
which are found in abundance in its leaves [3]. The present of 
those compounds caused the anti- cancer, antioxidant and 
antibacterial activities [3, 4]. There are several compounds from 
P. macrocarpa which are alreadypublished and reported. 
Phalerin(4,5-dihydroxy-4Ê-methoxybenzophenone-3-0--D-
glucoside)was isolated from P. macrocarpa  leaves [5].Icariside, 
phalerin, mangiferin[6], gallic acid [7], Isomer of phalerin [8, 9, 
10]were isolated from P. macrocarpa fruit. Moreover, 
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desacetylfevicordin, together with it derivatives were also isolated 
from seeds of P. macrocarpa[11]. All compounds above have 
already published as anticancer agent. 
 
Previous study reported that anticancer activity of the P. 
macrocarpa fruits and leaves were detected in Hela cells [12]. Its 
fruit was also showed anticancer activity againts leukemia cells 
[13], cervical cancer [14], and breast cancer ([15]. Meanwhile, 
theP. macrocarpa bark has anticancer activity against L1210 cells 
[16]. Moreover, anti-hypercholesterolemia activities from P. 
macrocarpa fruit extract in white rats has been studied by others 
researchers[17, 18]. 
 
Research on P. macrocarpa fruit and leaves merit have been 
done and published. However, there are no products and 
research related to the ability of compounds from P. macrocarpa 
leaves to lower the cholesterol substance (hypocholesterolemia). 
Antioxidant is one kind of the mechanisms which has a role in 
lowering cholesterol level. Antioxidant compound have been 
increased the expression of scavenger receptor class B type I 
(SR-B1) [19]. Antioxidant potencies of P. macrocarpa leaves 
extract was studied by Andrianiet al.[20]. They were reported the 
potential of ethyl acetate and methanol extractsofP. macrocarpa 
leaves as antioxidant agent.Thus, the isolated compoundsfromP. 
macrocarpa leaves extract might also have an antioxidant activity 
and ability in increasing of expression of key genes in cholesterol 
metabolism such as SR-B1.  
 
Materials and methods 
General Experimental Procedure 
Isolation of crude extracts were separated using gravity column 
chromatography, using silica gel 60 PF254 Art No. 7734 of particle 
size 0.063 ă 0.200 mm (Merck, Germany). For further separations 
of fractions were carried out by using vacuum column 
chromatography by using silica gel 60 PF254 Art No. 9385 of 
particle size 0.040 ă 0.063 mm. AR grade methanol, n-hexane, 
chloroform, ethyl acetate and methanol (Merck, Germany) were 
used in extraction and chromatographic analysis. The 1H and 13C 
NMR spectra were recorded on a FT-NMR Bruker Ultra Shield™ 
400 and 500 MHz spectrometers, as well as a Unity Inova Varian 
500 MHz spectrometer using tetramethylsilane (TMS) as internal 
standard. And  EI-MS spectra spectra was measured on 
ThermoFinnigan MAT 95 XL spectrometer..Melting point was 
determined by using instrument Model Perkin Elmer Pyris 6 Disc 
(Disc Scanning Calorimeter). IR spectra were recorded on 
spectrometer model Perkin Elmer Spectrum 100 FTIR 
Spectrometer using KBr disc. The adsorption bands were 
measured in cm-1. NMR Spectra were recorded on Varian Unity 
Inova 400 MHz (with Pulsed Field Gradient) instruments. 
Meanwhile, mass spectrum was measured on instrument model 
Trace GC Brand Thermo Finnigan. TMS was used as internal 
standard. Thin layer chromatography (TLC) was used to identify 
the number of component in extract and fraction mixture while 
obtained the appropriate solvent system for the column 
chromatography isolation. TLC profiling of HMD, CMD and EMD 
crude extracts were performed by  using TLC plastic sheets 
(Merck 1.05735.0001) which were pre-coated with silica gel 
60F254, and MMD extract on TLC Aluminum sheets  (Merck 
1.05559.0001) which were pre-coated with RP-18F254S . The TLC 
visualization was carried out by using UV-254nm, iodine vapour, 
DPPH TLC bioautographic assay (antioxidant potency tested), 
reagent spray with vanillin and ferric chloride (FeCl3). Then, 
compounds purification was carried out by recrystalization, and 
gravity column chromatography for non-polar or semi polar 
compound, meanwhile by C-18 packing column combined with 
VLC for very polar compound.. 
Plant Material  
Sample of P.macrocarpa leaves was collected from the same 
location of Bengkulu city, Indonesia, in 2008. The voucher 
specimen (SA1611/2008) has been deposited in the Herbarium of 
Bogoriense, Bogor, Indonesia. 
Extraction and Isolation 
Subsequently, the dried sample (500g) was soaked in solvent by 
successive extraction method [20] usinghexane, chloroform, ethyl 
acetate and methanol. The dried powder of leaves was extracted 
five times at room temperature for 24 hours. The extract were 
evaporated under reduced pressure to give 5% hexane (HMD), 
6% chloroform (CMD), 2.5% ethyl acetate (EMD), and 3.3% 
methanol (MMD). Based on antioxidant assay, MMD was used to 
the next step. MMD (35 g) was subjected to open column 
chromatography (23 cm x 8 cm) on Si gel 60 (230-400 mesh, 
Merck) gravity chromatography. The column was packed by 
Chloroform/MeOH (8:2) and then followed by gradient elution of 
sequential chloroform and methanol. The fractions were collected 
200 mL each, evaporated, labeled and monitored by TLC using 
water: acetonitril (6:4) as a solvent system. The fractions showed 
same TLC pattern were combined resulting in 10 fractions namely 
CF1-CF7. The active fractions (CF.3, 4, and 5) which was crystal 
in form were continued for further purification. Each them 
(CF.3=4.3g, CF.4=5.6g, CF.5=3.7g) were subjected to different 
sephadex LH-20 column chromatography (25cm x 4.5cm). The 
column was packed by chloroform/methanol (1:2) and then 
follows by chloroform and methanol (1:1) until finish. The fractions 
were collected 100 mL each, evaporated, labeled and monitored 
by TLC precoated C-18 using water: Acetonitril (6:4) as a solvent 
system.  CF.4 was yielded one active fraction (F4). Meanwhile 
CF.5 was yielded two active fractions (F5 and F6). Then, each 
fractions were subjected to medium pressure liquid 
chromatography (MPLC) glass column with reverse phase C-18 
and using water:acetonitril as solvent system, and  follow by 
gradient elution of sequential water and acetonitril. Fraction F4 
was yielded yellowish brown solid compound (MMD 2, 55mg). 
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Furthermore, F5 was yielded yellowish cotton compound (MMD4, 
30mg). Yellowish cotton compound (MMD5, 40mg) was obtained 
from fraction F6. Then, each compound was freeze dried to 
evaporate the water solvent. The purity were checked by TLC 
aluminium pre-coated sheets with reverse phase-18F254S  to show 
one spot. The TLC visualization was carried out by using UV-
254nm, iodine vapour, reagent spray with DPPH, vanillin and 
ferric chloride (FeCl3).  TLC visualization of MMD2 (55mg) and 
MMD4 (30mg) were showed the same Rf value (0.55) with 
water/acetate solvent system 6/4 (v/v) migrated, then they were 
combined as compound (1). Subsequently, MMD5 was showed Rf 
value at 0.45 as compound (2).  
4Ê,6-Dihydroxy,4-methoxybenzophenone -2-O-β-D-
gentiobioside 
Yellowish solid; m.p. 165ă167; IR Vmax (KBr) (cm-1): 3374 (OăH 
stretching), 2935 (C-H stretching), 1614 (C=O stretching), 1512, 
1436,(C=C aromatics). For 1H NMR (DMSO-d6, 500 MHz) and 
APT 13C NMR (,DMSO-d6, 100 MHz) spectroscopic data, see 
Table 1. EIMS m/z 259 [M]+, 166, 121. 
4Ê,6-dihydroxy,4-methoxybenzophenone -2-O-β-D-
glucoside 
Yellowish brown solid; m.p. 180ă181; IR Vmax (KBr) (cm-1): 3369 
(OăH stretching), 2937 (C-H stretching), 1616 (C=O stretching), 
1511, 1436,(C=C aromatics). For 1H NMR (MEOD, 400 MHz) and 
13C NMR (MeOD, 100 MHz) spectroscopic data, see Table 2. 
EIMS m/z 259 [M]+, 166, 121. 
Bioassay 
(1). Determination of antioxidant activity by DPPH. Stable Free 
Radical Scavenging Activity.  
The ability of extracts and pure compounds to scavenge the α, α-
diphenyl-β-picrylhydrazyl (DPPH) radical was measured as 
reported by Gadovet al.[21].  
(2). The effect of the isolated compounds on SR-B1 genes 
expression. 
Extraction of the Reporter Plasmid DNA. 
Two recombinant reports plasmid were used in this experiment, 
namely pGL-3 SR-B1 and pRL-CMV. In order to purify the 
recombinant plasmid used in transfection luciferase assay 
experiment, plasmid midi kit (Qiagen 100 protocol, cat no 12145) 
was used. Briefly 1 mL of recombinant vector combining pGL-3     
SR-B1 and pRL-CMV, respectively were transferred into  25mL  
LB broth in  erlenmeyer 50mL and incubated at 370C with shaking 
at 200 rpm for 16 hours. Then, the culture was transferred into 
backman tube and centrifuged at 6000 rcf for 15 minutes at 40C. 
Supernatant was removed and the pellet was air dried.  
Subsequently 4 mL Buffer P1 was transferred into the tube and 
mixed with pellet by vortexing 4 mL buffer P2 was then added, 
mixed and incubated at room temperature for 5 minutes. Next, 4 
mL buffer P3 was added and centrifuged at 12,000 rcffor  30 
minutes at 40C. The supernatant was transferred to another 
backman tube and re-centrifuged at 12,000 rcf for 15 minutes at 
40C. The supernatant was then applied into Qiagen-tip and 
allowed to enter the resin by gravity flow. The Qiagen-tip was 
washed with 2x10mL QC and the coagulant plasmid DNA was 
eluted with 5 mL QF by grafity flow. Subsequently DNA solution 
was mixed with 3.5 mL of isopropanol, mixed gently, and 
centrifuged at 15,000 g for 10 minutes. The supernatant was 
carefully removed and pellet was air dried for 5-10 minutes. 
Plasmid DNA was redissolved in a suitable volume (100-200øL) 
ddH2O. Then proceed to calibrate concentration by spectramax 
and double digestion of pGL3-SR-B1 plasmid to confirm the 
inserts using XhoI and Hind III. Distilled water was use as a blank. 
Then it was run by electrophoresis to make sure the plasmid was 
inexistence. 
Lipofectin®  Transfection. Transient transfection was carried out 
using Lipofectin® (Invitrogen) as described by the manufacturer. 
Prior to the day of transfection,   4-5 x 104 cells/mL were seeded 
in 96-well plates in a volume 200øL complete medium each well. 
The cell were incubated overnight  (18-24 hours) at 370C in a CO2 
incubator until the cells were 60-80% confluent. On the day 
transfection, two solution were prepared. In solution A, 24øL of 
Lifofectin was diluted in 600øL of MEM serum free medium and 
incubated for 10-20 minutes at room temperature. Solution B was 
prepared by mixing 4.5 øg pRL-TK  and 18 øg pGL3-SR-B1 in the 
final volume of 600 øL MEM serum free medium and left at room 
temperature for 10-20 minutes. pRL-TK contains the cDNA 
encoding Renila luciferase driven by thymidine kinase minimal 
promoter element reporter gene was normalized against for 
transfection efficiency.  Then, both solution A and B was mix 
gently and incubated at room temperature for 10-15 minutes. 
Subsequently, 12 mL of fresh MEM serum free medium was 
added and mix well. For transfection, the growth medium was 
removed from the cells and wash once with PBS. Subsequently, 
100 øL of transfection medium was added into each well and 
incubated at 370C for 12 hours. Then the cell were washed with 
PBS twice and treated with variousconcentrations (3,1; 6,3; 12,5; 
25,0; 50,0; 100øg/mL) of compounds/extracts in 100 øL volume of 
fresh medium and incubated at 370C for 24 hours. The cells were 
then lysed and promoter activity was assayed. 
 
Assay of Luciferase Activity. 
Luciferase activity was measured using Dual-Luciferase® 
Reporter Assay System (Promega) where the activities of firefly 
(Photinuspyralis) and Renilla (Renillareniformis) luciferases were 
measured sequentially from a single sample. Following treatment, 
the cells were subjected to luciferase assay. Briefly, 25 øL of 
medium was removed from each well and 75 øL dual glo stop and 
glo luciferase reagent was added to each well, incubated for 10 
minutes and Renilla luciferase activity (as the control for 
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transfection efficiency) measured. All the luminescence reading 
were then substrated against the untreated sample. The SR-B1 
promoter luminescences reading were then normalized against 
pRL-TK luminescence reading for each respective concentration. 
Luminescence reading taken from transfected cells treated with 
rosiglitazone (positive control) was assigned as 100% and the 
readings from treated cells were then calculated as relative to the 
positive control (Result calculated as ratio of SR-B1 promoter 
expression of samples compared to control   x 100%). It was 
called as relative induction (% of control). 
 
Result and Discussion 
Structure elucidation 
IR spectrum of compound (1) showed absorption bands at 3374 
cm-1 indicating the presence of aromatic -OH group. Absorption 
band at 2935 cm-1 indicated the presence of saturated C-H group. 
Absorption bands at 1512 cm-1 and  1436 cm-1 represented as 
conjugated C=C aromatic. Absorption band at 1163 cm-1 and 
1075 came from C-O stretching. Characteristic absorption band at 
1614 cm-1 and  1280 cm-1  strongly correlated with C=O functional 
group4Ê,6-Dihydroxy-4-methoxybenzophenone-2-O--D-
gentiobioside or 4Ê,6-di hydroxy-4methoxybenzophenone-2-O-[-
D-glucopyranosyl-(1ā6)--D-glucopyranoside] was isolated from 
MMD extract from  P. macrocarpa  leaves. The compound 
physically is a yellowish solid. The 1H NMR data showed the 
hydroxy protons (-OH) as two singlets at Ē 6.70 (1H, s) and 10.30 
(1H, s) substituted at carbon 4Ê (Ē 160.8) and 6 (Ē 161.3) which 
correlated to benzophenone. The existing of -OH supported by IR 
data at 3374 cm-1.The assignment of carbon and proton were 
established by using the HSQC and HMBC correlation (Figure 1). 
The presence of the same para-substituted symmetric phenol ring 
as appeared as deshielded signals at Ē 7.936 (2H, J=7.2 Hz) and 
6.932 (2H, J =9.0 Hz). The aromatic protons of the other ring 
displayed two doublets at Ē 6.87 (1H, d, J=2.4 Hz) and 7.03 (1H, 
d, J=2.4 Hz), characteristic for a meta coupling and these 
correlation established by COSY experiment data, and it also 
showed the specific ortho-coupling between proton Ē 7.93 (2H, d, 
J=7.2 Hz) and Ē 6.93 (2H, d, J=9.0 Hz). 
 
From APT 13C NMR spectrum data, compound (1) carbon atoms 
consisted of one=CH3 (Ē 56.0), one=C=O (Ē 176.8), two=CH2 (Ē 
68.6 and Ē 65.6), six =C- and others appeared as C-H (data 
showed in Table 1). The APT 13C NMRand 1H NMR spectrums 
suggested the presence of a methoxy group (1H: Ē  3.90; 13C: Ē  
56.08), where Its position was assigned in C-4 to an HMBC 
correlation experiment (Figure 1). A signal at Ē 176.8, typical for 
the carbonyl group of a benzophenone.The existing of C=O 
supported by IR data at 1614 cm-1 indicating the C=O was 
ketone-substituted aromatic ring (Silverstein et al., 1991). Carbon 
signals which appeared at Ē 104.7 - 65.6 were specific for 
gentiobiosidemoeity and other characterize signals of aromatic 
carbons appeared at Ē 96.6 ă 163.5.  1H and 13C assignments for 
compound (1) showed on Table 1. The presence of an O--D-
gentiobioside was confirmed by the characteristic 1H signal for the 
anomeric proton at Ē 4.78 (H-1‰), its linkage position at C-2 of 
benzophenone was ascertained by HMBC correlations (Figure 1). 
The presence of an O--D-glucopyranoside was confirmed by 
other 1H signal for ananomeric proton at Ē 4.20 (H-1Ê‰) with 
linkage position at C-6‰ (1ā6) which is showed correlation 
between two glucoses in gentiobiose.  An -anomeric protons both 
of them was confirmed by appear as doublets with J = 7.8 Hz. 
This is agreement with Agrawal[22] and Ferrrariet al. [23],  which 
they reported that -anomeric protons appear as doublets with 
3J1,2 in the range 6.0 - 7.8 Hz.  Moreover, hydroxy signals were 
observed as a singlet signal at Ē  6.70 ppm  and Ē 10.30 ppm as 
they was shown by the absence of carbon directly attached to ăH 
signal on the  13C-1H 2D-NMR (HSQC) spectra. The MS spectrum 
suggested the molecular formula C26H32O15. The molecular 
formula of compound (1) which has relative molecular mass 584 
g/mol was determined on the basis of EI-MS.  The EI-MS analysis 
confirmed the loss of this sugar moiety with a base peak at m/z 
259 [M-Gentiobiose-H]+. The fragmentation ion of compound (1) 
at m/z 166 and 121 are due to the fission of ring. Therefore, a 
chemical IUPAC name of compound (1) is 4Ê,6-dihydroxy-4-
methoxybenzophenone-2-O-[-D-glucopyranosyl-(1ā6)--D-
glucopyranoside] or 4Ê,6-dihydroxy-4-methoxybenzophenone-2-O-
-D-gentiobioside (Figure 2). Confirm that compound (1) is a new 
compound as it has not found yet both in leaves, fruits and other 
part of P. macrocarpa and also not published yet elsewhere.  
 
Compound (2), namely 4Ê,6-Dihydroxy,4-methoxybenzophenone-
2-O--D-glucopyranoside was isolated from MMD extract from  P. 
macrocarpa  leaves. The compound (2) appeared as a yellowish 
brown solid with melting point 180-181 0CandRf valueis0.35. The 
IR spectrum data indicated the presence of aromatic hydroxyl 
group (3369 cm-1, broad), C-H stretching at 2937 cm-1, and 
conjugated carbon-carbon bonds (C=C) at 1616 cm-1. Moreover, 
Bands at 1511 cm-1 and 1436 cm-1 showed the present of 
aromatic ring due to  C=C group.  The signal of 1H NMR (400 
MHz, MeOD) data indicated that the presence of aromatic proton 
group which correlated to benzophenone skeleton hydroxy group 
(-OH) at Ē 4.9 substituted at carbon  4Ê and 6. The existing of -OH 
supported by IR data at 3369 cm-1. Deshielded signals appeared 
at Ē 7.72 (2H, d, J=8.8 Hz) and 6.82 (2H, d, J =8.8 Hz) showing 
the presence of the same para-substituted symmetric phenol ring. 
The aromatic protons of the other ring displayed two doublets at Ē 
6.19, J=2.4 Hz) and 6.42, J=2.4 Hz), characteristic for a meta 
coupling, it was established by COSY experiment. The 1H-1H 
COSY spectrum showed the characteristic ortho-coupling 
correlations between proton Ē 6.82 (2H, d, J=8.8 Hz) and Ē 7.72 
(2H, d, J=8.8 Hz), and the specific meta-coupling correlation 
between proton Ē 6.19 (1H, d, J=2.4 Hz) and Ē 6.42 (1H, d, J=2.4 
Hz). 
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Table 1: 1D-NMR ( 1H and 13C NMR) and 2D-NMR assignments (500MHz, DMSO-d6) for compound (1)
 
Compound  (1) 
Position 
-C- 
13C-NMR (Ē, ppm) Position 
-H- 
1H-NMR  
 (Ē, ppm, J=Hz) 
HMBC Correlation 
1J 2J 3J 
-C=O 176.8 - -  C-6  
C-4 163.5 - -    
C-6 161.3 - -    
C-4Ê 160.8 - -    
C-2 158.1 - -    
C-2Ê 
128.0 
H-2Ê 7.93(2H, d, 7.2)   C-4Ê, C-6Ê 
C-6Ê H-6Ê   C-2Ê, C-4Ê 
C-1Ê 115.8 - -    
C-3Ê 
115.8 
H-3Ê 6.93(2H, d, 9.0)   C-1Ê, C-5Ê 
C-5Ê H-5Ê   C-2Ê, C-3Ê 
C-1 109.1 - -    
C-1‰ 104.7 H-1‰ 4.78(1H, d, 7.8)  C-2 C-5‰ 
C-1‰Ê 103.7 H-1‰Ê 4.20(1H, d, 7.8)  C-6‰ C-6‰Ê 
C-3 102.9 H-3 6.87(1H, d, 2.4) C-3 C-2, C-4 C-1, C-5 
C-5 96.6 H-5 7.03(1H, d, 2.4)  C-4 C-1, C-3 
C-3‰Ê 76.5 H-3‰Ê 3.12(1H, m)    
C-5‰ 75.9 H-5‰ 3.57(1H, m)    
C-3‰ 75.6 H-3‰ 3.30(1H, m)    
C-2‰ 73.4 H-2‰ 2.99(1H, m)    
C-4‰Ê  H-4‰Ê 3.38(1H, d.1.8)    
C-5‰Ê 73.3 H-5‰Ê 3.36(1H, d.1.8)    
C-4‰ 69.7 H-4‰ 3.26(1H, m)    
C-2‰Ê 69.5 H-2‰Ê 3.28(1H, m)    
C-6‰Ê 68.6 H-6‰Êa 3.99(1H, d, 10.2)   C-1‰Ê 
- - H-6‰Êb 3.65(1H, dd, 4.8;11.4)   C-1‰Ê 
C-6‰ 65.6 H-6‰a 3.70(1H, dd, 5.4;10.8)  C-1‰Ê C-2‰Ê 
- - H-6‰b 3.04(1H, d,10.8)  C-1‰Ê C-2‰Ê 
OCH3 56.0 -OCH3 3.90(3H,s)    
  -OH 6.70(s) C-6 C-1 C=O 
  -OH 10.30(s) C-4Ê   
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Table 2: 1D-NMR ( 1H and 13C NMR) and 2D-NMR assignments (400MHz, MeOD) for compound (2) 
Compound  (2) 
Position 
-C- 
13C-NMR (Ē, ppm) Position 
-H- 
1H-NMR  
 (Ē, ppm, J=Hz) 
HMBC Correlation 
2J 3J 
-C=O 195.6 - -   
C-4 162.8 - -   
C-4Ê 162.4 - -   
C-6 157.6 - -   
C-2 157.0 - -   
C-2Ê 132.1 
H-2Ê 7.72(2H,d,8.8) C=O C-4Ê 
C-6Ê H-6Ê  C=O C-2Ê, C-4Ê 
C-1Ê 130.4 - -   
C-3Ê 114.5 
H-3Ê 6.82(2H,d,8.8) C-4Ê C-1Ê,C-5Ê 
C-5Ê H-5Ê   C-1Ê, C-3Ê 
C-1 110.3 - -   
C-1‰ 101.1 H-1‰ 4.88(1H, s) C-2  
C-5 95.3 H-5 6.19(1H,d, 2.4) C-4,C-6 C-1,C-3 
C-3 93.4 H-3 6.42(1H,d, 2.4) C-2,C-4 C-1,C-5 
C-5‰ 76.9 H-5‰ 3.42(1H,m) C-4Ê  
C-3‰ 76.4 H-3‰ 3.39(1H,m) C-2‰  
C-2‰ 73.3 H-2‰ 3.15(1H,t, 7.6;9.2) C-1‰,C-3‰  
C-4‰ 69.8 H-4‰ 3.27(1H,m) C-5‰ C-6‰ 
C-6‰ 61.2 H-6‰ 3.67(2H,dd,6.0;12.0) C-5‰  
-OCH3 54.5 OCH3- 3.82(3H, s) C-4  
  -OH 4.90   
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The 13C NMR spectrum data showeda signal at Ē 195.6, typical for 
the carbonyl group of a benzophenone, and 12 carbons 
assignment of this structure gives in Table 2.  The existing of C=O 
supported by IR data at 1616 cm-1 indicating the C=O was 
ketone-substituted aromatic ring [24]. 13C NMR signals which 
correlated to doublets 1H NMR signal showed at Ē 132.1 (C-2Ê and 
C-6Ê) and 114.5 (C-3Ê and C-5Ê). Carbon signals at chemical shift Ē 
101.1 (C-1„), 76.9 (C-5‰), 76.4 (C-3‰), 73.3 (C-2‰), 69.8 (C-4‰), and 
61.2 (C-6‰) were specific for glucoside moiety. Others carbon 
signals of aromatic carbons `of benzophenone at chemical shift Ē 
162.8 (C-4), 162.4 (C-4Ê), 157.6(C-6), 157.0 (C-2), 130.4 (C-1Ê), 
95.3 (C-5) and 93.4 (C-3), confirmed the structure hypothesis.  
Spectrum data of HMQC, HMBC and COSY experiments allowed 
complete assignment and identification of the aglycone. 1H and 
13C NMR suggested the presence of a methoxy group (1H: Ē3.82; 
13C: Ē 54.5) of benzophenone structure. Its position was assigned 
in C-4 (Ē 162.8) according to the HMBC (Figure 1) correlation 
experiment. The presence of an O--D-glucose was also 
confirmed by the characteristic 1H signal for the anomeric proton 
at  Ē 4.88 [22]. Its linkage position at C-2 was ascertained by 
HMBC (Figure 1). Usually, -anomeric protons appear as doublets 
with 3J1,2 in the range 6.0 - 6.8 Hz [22] and around 7.8 Hz[23]. 
Meanwhile, there was not shown double peak in this study, it 
could be caused by compound (2) has an anomeric proton 
chemical shift quite same with proton chemical shift of the solvent 
(overlapping between MeOD and compound (2), those why the 
double peak was not appear. Moreover, hydroxy signal was 
observed as a broad signal at Ē  4.90 ppm corresponded to ăOH 
sugar as it was shown by the absence of carbon directly attached   
to ăH signal (Ē  4.90 ppm) on the  13C-1H 2D-NMR (HMQC) 
spectra data. The Hydroxyl signal at 4.90ppm could be also effect 
on the appearance of anomeric proton.   
 
 
 
 
 
 
(1) 
 
 
 
 
(2) 
 
Figure1: Selected HMBC (HāC) correlations exhibited by 
compound (1) and (2). 
The EI-MS spectrum pattern together with 1H and 13C NMR 
spectra suggested that molecular formula for compound (2) was 
C20H22O10  (Figure 2). The EI-MS analysis confirmed the loss of 
this sugar moiety with a base peak at m/z 259 [M-Glc-H]+. The 
fragmentation ion at m/z 166 and 121 are due to the fission of ring 
based on fragmentation ion pattern from Aripin[9]. Therefore, a 
chemical IUPAC name of compound (2) is 4Ê,6-dihydroxy-4 
methoxybenzophenone-2-O--D-glucopyranoside (Figure 2). The 
spectrum pattern of this compound is similar to 4Ê,6-dihydroxy-4-
methoxybenzophenone-2-O--D-glucopyranosidewhich has been 
isolatedfrom P. macrocarpafruit [6, 9] and bark [16]. Similar 
compound, but the glucoside moiety was an đ-anomeric, 
namely4Ê,6-dihydroxy-4-methoxybenzophenone-2-O-đ-D-
glucopyranosidewas also obtained from P.macrocarpa fruits [8]. 
 
 
 
 
 
(1) 
 
 
 
 
(2) 
 
Figure 2: Structure of 4Ê,6-Dihydroxy-4-methoxybenzophenone-2-
O--D-gentiobioside or 4Ê,6-dihydroxy-4-methoxybenzophenone-2-
O-[-D-glucopyranosyl-(1ā6)--D-glucopyranoside] (1) and 4Ê,6-
dihydroxy-4-methoxybenzophenone-2-O--D-glucoside (2) 
Antioxidant activity (DPPH free radical scavenging 
ability) 
Evaluation of antioxidant activity of P.macrocarpa leaves extracts 
was adapted from Gadovet al. [21] with some modifications. 
Crude extract of MMD and EMD exhibited a strong and moderate 
free radical scavenging with the inhibition percentages are 79 and 
76%, respectively. Crude extract of HMD and CMD exhibited low 
and moderate inhibition with percentages ranging from 59-69% 
(data not shown). Meanwhile, 4Ê,6-dihydroxy,4 
methoxybenzophenone -2-O--D-gentiobioside (1) and 4Ê,6-
dihydroxy,4 methoxybenzophenone -2-O--D-glucopyranoside (2) 
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